Investing Women Angels

Investing Women is an angel investment network based in Edinburgh, United Kingdom, founded in 2013. It fosters a community of women angel investors and entrepreneurs, aiming to support and empower women in business. The organization seeks to create a collaborative environment where women can invest in and help grow emerging companies. By building a pool of female investors, Investing Women acts as a catalyst for fostering the next generation of successful businesses, emphasizing the importance of networking and mentorship in the investment landscape. The initiative goes beyond financial contributions, focusing on the broader goal of empowering women in entrepreneurship.

Pamela Barclay

Board Member

6 past transactions

Carcinotech

Seed Round in 2024
Carcinotech is a pioneering company in cancer research, specializing in the manufacturing of 3D-printed micro-tumors derived from patient biopsies, primary cells, immune cells, and cancer stem cells. The company aims to enhance the drug screening process and facilitate pre-clinical and personalized medicine testing, ultimately accelerating the delivery of more effective cancer treatments to market. By employing advanced techniques in tissue engineering, robotic manufacturing, and stringent quality control, Carcinotech produces highly predictive, assay-ready printed tumors that reflect the heterogeneity of individual cancers. This innovative approach provides clinicians with models of "clinical biopsy" quality, significantly improving the accuracy of cancer treatment assessments. Collaborating with global partners, including leading pharmaceutical companies and medical professionals, Carcinotech is committed to transforming oncology drug development and increasing the likelihood of successful outcomes for cancer patients.

Terrible*

Venture Round in 2023
Terrible* is a platform designed for artists, apparel designers, data scientists, and entrepreneurs. It facilitates the creation, sourcing, and delivery of unique products for fans or at live events. The company offers full-service management, handling merchandise operations efficiently to enhance brand visibility and engagement. This enables artists to monetize their fanbase while minimizing operational stress.

Cytochroma

Seed Round in 2021
Cytochroma manufacture genetically diverse stem cell-derived models to predict the safety and effect of drugs in a global population. Cytochroma’s automated cell manufacture, physiologically relevant models and rapid screening platform makes preclinical testing faster, safer and smarter.

ScotBio

Venture Round in 2018
ScotBio is a Scotland-based biotechnology company that grows algae indoors in closed, hygienic vessels to produce natural, clean-label ingredients for food, beverage, nutrition, textiles, cosmetics, and pharmaceuticals. The company develops natural blue pigments, carotenoids and alternative protein from spirulina, and its blue extract is manufactured in stainless steel reactors for use as a food colorant and as an additive for alcoholic beverages, as well as a healthy ingredient in pet food formulations.

Novosound

Venture Round in 2018
Novosound Ltd, founded in 2016 and based in Edinburgh, United Kingdom, specializes in the design and manufacture of innovative ultrasound sensors that address the limitations of traditional technology. As the first spin-out from the University of the West of Scotland, Novosound employs groundbreaking thin-film manufacturing techniques to create highly customizable and scalable ultrasound solutions. The company’s products are utilized across various sectors, including aerospace, oil and gas, industrial applications, as well as in medical, veterinary, and dental fields. By developing advanced imaging sensors, systems, and software, Novosound enhances high-resolution ultrasound imaging, thereby providing clients with improved capabilities in non-destructive testing and diagnostics.

Chromacity

Seed Round in 2015
Chromacity Ltd. is a company based in Edinburgh, United Kingdom, specializing in the development, manufacturing, and distribution of wavelength tunable femtosecond lasers. Founded as a spin-out from Heriot-Watt University in 2013, it boasts a founding team with over 40 years of experience in ultrafast lasers. Chromacity's product lineup includes several advanced lasers such as the Spark 1030-nm and Spark-HP 1040-nm femtosecond lasers, designed for life sciences and spectroscopy applications. The company also offers Spark-X and Spark-OPO models, which provide tunable femtosecond pulses across various wavelengths for applications in two-photon stimulation and spectroscopy, respectively. Their robust, patent-pending fiber-laser technology ensures reliable performance, complemented by a user-friendly web-based interface for easy operation. In addition to standard products, Chromacity collaborates with systems manufacturers to create custom OEM femtosecond and picosecond lasers tailored for specific engineering and materials processing needs. The company serves a global customer base across North America, the UK, and the Middle East.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.